SCHEMBL4909709

SCHEMBL4909709

CN(C)C(=O)c1cc2c(-c3ccc(Cl)cc3)nc(N)nc2s1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AB1 P08238 11/20 0.67
ICAM1 P05362 1/20 0.44
SELE P16581 1/20 0.44
VCAM1 P19320 1/20 0.44
CCNC P24863 1/20 0.44
CDK8 P49336 1/20 0.44
ADORA2A P29274 1/20 0.40
ADORA1 P30542 1/20 0.40
NUDT1 P36639 1/20 0.39
CNR1 P21554 1/20 0.39
HSP90AA1 P07900 2/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
HSD17B10 Q99714 1/20 0.39
CYP2C19 P33261 1/20 0.38
BRAF P15056 1/20 0.38
PDE4A P27815 1/20 0.38
PDE4B Q07343 1/20 0.38
PDE4C Q08493 1/20 0.38
PDE4D Q08499 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14317540 0.89 HSP90AB1 (0.54) HSP90AB1ADORA2AADORA1NUDT1KDM4E
SCHEMBL4911759 0.83 HSP90AB1 (0.78) HSP90AB1ICAM1SELEVCAM1CCNC
SCHEMBL13109969 0.81 HSP90AB1 (0.70) HSP90AB1ALDH1A1HSD17B10
SCHEMBL13109976 0.81 HSP90AB1 (1.00) HSP90AB1ICAM1SELECCNCCDK8
SCHEMBL4907307 0.77 HSP90AB1 (0.69) HSP90AB1CNR1KDM4EALDH1A1
SCHEMBL4907932 0.76 BRAF (0.57) HSP90AB1KDM4EALDH1A1BRAFPDE4A
SCHEMBL14281576 0.75 HSP90AB1 (0.57) HSP90AB1ADORA2AADORA1HSP90AA1CYP2C19
SCHEMBL14281568 0.75 HSP90AB1 (0.56) HSP90AB1HSP90AA1KDM4ECYP2C19BRAF
SCHEMBL4908426 0.74 HSP90AB1 (0.61) HSP90AB1ICAM1SELEVCAM1CCNC
SCHEMBL4904073 0.73 BRAF (0.62) HSP90AB1ICAM1SELEBRAFPDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1984377-A2 INHIBITORS OF TNF ALPHA , PDE4 AND B-RAF, COMPOSITIONS THEREOF AND METHODS OF USE THEREWITH Signal Pharmaceuticals LLC (US) 2008-10-29 EP disclosed
US-20080004271-A1 Inhibitors of TNFalpha, PDE4 and B-RAF, compositions thereof and methods of use therewith MCKENNA JEFFREY M 2008-01-03 US disclosed
US-20080004271-A1 Inhibitors of TNFalpha, PDE4 and B-RAF, compositions thereof and methods of use therewith MCKENNA JEFFREY M 2008-01-03 US disclosed
US-20080004271-A1 Inhibitors of TNFalpha, PDE4 and B-RAF, compositions thereof and methods of use therewith MCKENNA JEFFREY M 2008-01-03 US disclosed
WO-2007084560-A2 INHIBITORS OF TNFα, PDE4 AND B-RAF, COMPOSITIONS THEREOF AND METHODS OF USE THEREWITH SIGNAL PHARMACEUTICALS, LLC (US) 2007-07-26 WO disclosed
WO-2007084560-A2 INHIBITORS OF TNFα, PDE4 AND B-RAF, COMPOSITIONS THEREOF AND METHODS OF USE THEREWITH SIGNAL PHARMACEUTICALS, LLC (US) 2007-07-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004271-A1 Inhibitors of TNFalpha, PDE4 and B-RAF, compositions thereof and methods of use therewith PDE4A, PDE4B, BRAF HSP90AB1 1347/4885ICAM1 3630/4885SELE 3764/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.